Complementary and Alternative Medicines in Prostate Cancer A Comprehensive Approach

Recent global cancer statistical data has clearly indicated that prostate cancer is currently the second most frequently diagnosed cancer (at 15% of all male cancers) and globally the sixth leading cause of cancer death in males. This book is a summary of prostate cancer, covering its incidence, epidemiology, and current treatment options. It also serves as an up-to-date review of the status of currently available alternative and complementary medicines for treating prostate cancer, including various plant extracts, herbal formulations, natural products, yoga, acupuncture, Ayurveda, homeopathy, and Siddha medicines used in prostate cancer therapy.

Prostate cancer: an introduction. Prostate cancer epidemiology. Molecular biology of prostate cancer. Current treatments and reasons for treatment failure. Preclinical status of novel approaches for prostate cancer therapy. Triterpenoids and sesquiterpenes. Curcumin. Resveratrol.Complementary and Alternative Medicines in Prostate Cancer: From Bench to Bedside. Phyllanthus sp: Bitter melon extract. Kava. Plumbagin. Urokinase inhibitors from plants. Chinese Herbal among Prostate Cancer Patients: A Population-Based Study in Taiwan. lternol.Betel leaf.Spice derived anticancer molecules for prostate cancer. Nutraceuticals and prostate cancer. Isoflavinoids. Pomegranate. Green tea. Broccoli. Pomi-T supplements. Other forms of CAM. Yoga and prostate cancer. Acupuncture. Homeopathy. Siddha medicines.

K. B. Harikumar, Ph.D., received his bachelor’s and master’s degrees in biochemistry from Nagpur University in India. His doctoral research on cancer chemoprevention by natural products was conducted under the direction of Dr. Ramadasan Kuttan at Amala Cancer Research Center, affiliated with Mahatma Gandhi University at Kottayam in India. He has over 40 peer-reviewed publications and several book chapters to his credit. His major research focuses are cancer chemoprevention, ubiquitination and nuclear factor kappa B signaling, and the role of bioactive lipids in cell signaling.